ACCC says makers of drug should have been fined at least $6m instead of $1.7m because it made millions from products it claimed targeted specific pain
The consumer watchdog is appealing what it says is an inadequate fine imposed by the federal court against the makers of Nurofen over misplaced claims of targeted pain relief.
The Australian Competition and Consumer Commission says Reckitt Benckiser should have been fined at least $6m, rather than the $1.7m imposed, because the company made millions from products it misleadingly claimed were tailored to treat specific pain.
Continue reading...from
http://ift.tt/1YQcF5p
No comments:
Post a Comment